Sinemet Cr

Basic Sinemet CR information

• INN (international nonproprietary name): Carbidopa and levodopa
• Brand names available in the United Kingdom: Sinemet CR (prolonged-release tablets 50 mg carbidopa/200 mg levodopa) and Half Sinemet CR (25 mg/100 mg)
• ATC code: N04BA02
• Forms and dosages: Prolonged-release tablets 50 mg/200 mg and 25 mg/100 mg
• Manufacturers in the United Kingdom: Merck Sharp & Dohme (MSD)
• Registration status in the United Kingdom: Prescription-only medicine (POM)
• OTC / Rx classification: Prescription-only medicine (POM)

Everyday use and best practices

For people with Parkinson's disease, taking Sinemet CR at regular times each day helps to maintain consistent effects.

Morning vs evening dosing

Doses are taken at set intervals through the day, with a dose at bedtime if there are motor fluctuations at night. Above all, consistency in dosing times is essential to maintain stable levels of the medicine in the bloodstream.

Taking with or without meals

Taking Sinemet CR with a light snack can ease side effects such as nausea. Consider the following tips:

• Swallow the tablets whole (they may be halved but must not be crushed or chewed).
• Large high-protein meals can interfere with absorption, so space them from your doses where possible.
• A light snack may help if nausea occurs.

Safety priorities

Who should avoid it

While Sinemet CR can be highly effective, several conditions warrant caution or avoidance. Individuals with hypersensitivity to carbidopa or levodopa should not use this medication. It is also not suitable for people with narrow-angle glaucoma, and caution is needed in severe cardiovascular disease. Always consult healthcare providers before starting this medicine, especially if you have any pre-existing conditions or are taking other medicines.

Activities to limit

Operating machinery or driving might pose risks if a patient experiences side effects from Sinemet CR. Side effects like dizziness, confusion or sudden sleepiness can impair your ability to engage in these activities safely. Do not drive if you are affected, and consult your doctor about work-related safety.

Dosage and adjustments

General regimen

The usual starting dose is 1 tablet of 50 mg/200 mg at intervals of about 6 to 8 hours. For those transitioning from immediate-release products, the dose may need to be adjusted because of differences in bioavailability. Patients usually do not exceed eight tablets per day (an upper limit of 1600 mg of levodopa). The dose is personalised by the prescriber, with ongoing monitoring for adverse effects.

Special cases

For older individuals, starting with the lowest effective dose is advisable, with careful titration. Monitoring is important for patients with liver or kidney impairment.

What’s inside and how it works

Ingredients overview

Sinemet CR is a combination medication composed of two key ingredients: carbidopa and levodopa. These components work closely to manage the symptoms of Parkinson's disease. Levodopa is converted into dopamine in the brain, addressing the dopamine deficiency that characterises Parkinson's. Carbidopa, on the other hand, inhibits the conversion of levodopa to dopamine outside the brain, ensuring more levodopa reaches the brain without being prematurely converted. This synergistic effect allows for better control of motor symptoms associated with the condition.

Mechanism basics explained simply

In simple terms, Sinemet CR offers a specialised way to deliver levodopa over an extended period. Once taken, the medicine slowly releases levodopa, which the brain uses to replenish low dopamine levels. This gradual release helps to reduce the fluctuations in symptoms that can occur with immediate-release forms and shorten 'off' periods.

Main indications

Approved uses (MHRA listing)

Sinemet CR is licensed in the UK for the treatment of idiopathic Parkinson's disease. Patients experiencing motor fluctuations, known as 'off periods', can particularly benefit from this prolonged-release formulation.

Off-label uses in UK clinics

Sinemet CR might occasionally be prescribed by specialists for use outside its licence, for example in less common variants of Parkinson's disease symptoms.

Interaction warnings

Food interactions (alcohol, tea/coffee)

Patients taking Sinemet CR should exercise caution with certain food and beverages. Alcohol can add to side effects such as dizziness and low blood pressure, and large high-protein meals can reduce absorption of levodopa. Alcohol is best avoided, and a consistent meal schedule helps to maintain steady absorption.

Drug conflicts

Several medicines can interact with Sinemet CR, such as non-selective MAO inhibitors (which must not be used), certain antidepressants, antipsychotics and iron supplements. Tell your prescriber and pharmacist about everything you take. Suspected side effects can be reported through the Yellow Card scheme.

Alternative choices

Other NHS-prescribed options for Parkinson's disease include:

The choice between Sinemet CR, Madopar and Stalevo depends on individual patient needs.

Regulation snapshot

Sinemet CR, which combines carbidopa and levodopa, is a prescription-only medicine (POM) licensed by the Medicines and Healthcare products Regulatory Agency (MHRA) in the UK for the symptoms of Parkinson's disease, providing prolonged relief for patients with motor fluctuations. Healthcare professionals assess individual patient needs, specifically symptom severity and responsiveness to existing treatments.

Frequently asked questions

Common questions about Sinemet CR:

• What is Sinemet CR used for? Sinemet CR is primarily used to treat Parkinson's disease, helping to manage symptoms like tremors and stiffness.
• How should I take Sinemet CR? It’s typically taken in divided doses throughout the day, following your doctor's dosage recommendations. Do not crush or chew the tablets.
• What side effects should I expect? Common side effects include nausea, dizziness, and fatigue. Serious reactions like hallucinations or arrhythmias are rarer but require immediate medical attention.
• Can I get Sinemet CR without a prescription? No – in the UK Sinemet CR is a prescription-only medicine and should always be taken under medical supervision.

Guidelines for proper use

When using Sinemet CR, proper management is crucial for maximum benefit:

• Take regularly: Adhering to the prescribed schedule helps maintain steady medication levels in the bloodstream.
• Monitor health: Regular follow-ups with a healthcare provider are essential to adjust dosages and mitigate side effects.
• Be aware of side effects: Keeping track of any adverse reactions will assist your healthcare professional in managing your treatment effectively.
• Diet considerations: large high-protein meals can interfere with the absorption of Sinemet CR; it's advisable to space them from your doses.
• Stay informed: tell your healthcare team about any new symptoms or health changes.

For support, the NHS offers various resources, including medication reviews and guidance on lifestyle adjustments to complement medication therapy.

Delivery information for Sinemet CR